000 | 01372 a2200373 4500 | ||
---|---|---|---|
005 | 20250517132616.0 | ||
264 | 0 | _c20170905 | |
008 | 201709s 0 0 eng d | ||
022 | _a1875-5992 | ||
024 | 7 |
_a10.2174/1871520617666170103095527 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGuan, Haixing | |
245 | 0 | 0 |
_aDevelopment of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies. _h[electronic resource] |
260 |
_bAnti-cancer agents in medicinal chemistry _c2017 |
||
300 |
_a646-657 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCyclin-Dependent Kinase 4 _xantagonists & inhibitors |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aDu, Yongli | |
700 | 1 | _aHan, Weiwei | |
700 | 1 | _aShen, Jingkang | |
700 | 1 | _aLi, Qunyi | |
773 | 0 |
_tAnti-cancer agents in medicinal chemistry _gvol. 17 _gno. 5 _gp. 646-657 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1871520617666170103095527 _zAvailable from publisher's website |
999 |
_c26748241 _d26748241 |